Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ascend Vitality vs Neo Soma Healthcare

Ascend Vitality
Graded #307

Lower grade

vs+4.899999999999999
Neo Soma Healthcare
Graded #213

Higher grade

The verdict

Neo Soma Healthcare takes it — 65.8/100 to 60.9/100.

Neo Soma Healthcare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Neo Soma Healthcare is a multi-product DTC telehealth platform pairing compounded GLP-1 weight management with sexual-health and anti-aging lines.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNeo Soma Healthcare +16
50
66
Dose & formulationAscend Vitality +3
75
72
Clinical oversightAscend Vitality +2
74
72
Labs & monitoringNeo Soma Healthcare +10
52
62
FulfillmentAscend Vitality +8
65
57
Contract termsNeo Soma Healthcare +18
37
55
Ascend Vitality · left barNeo Soma Healthcare · right bar

The numbers

MetricAscend VitalityNeo Soma Healthcare
WeighScore60.9/10065.8/100
GradeCC
Scorecard rank#307#213
Semaglutide$199/mo (compounded)$199/mo
Tirzepatide$299/mo (compounded)$330/mo
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Ascend Vitality

Graded #307 · C

Strengths

  • Both injectable and needle-free oral tablet forms of semaglutide and tirzepatide
  • LegitScript certified
  • Transparent cash-pay pricing with cancel-anytime subscription
  • Legal entity and address publicly disclosed (Ascend Vitality LLC, Sheridan, WY)

Where it loses points

  • All medications are compounded — FDA does not review compounded drugs for safety/effectiveness
  • No named compounding pharmacy partner disclosed
  • No public state-by-state availability list (homepage cites exclusions: LA, MS, KS, NM, WV)
  • Per-dose/titration pricing not published; only 'starting at' prices shown
Neo Soma Healthcare

Graded #213 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

Where it loses points

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard